ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.37
0.61%
US Tech 100
21,214.46
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,305.27
-1.28%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Ishares Msci India Etf (0JKT) 시세

Ishares Msci India Etf

Ishares Msci India Etf (0JKT)

LSE
28.035
0.00
(0.00%)
마감 23 1월 1:30AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
28.035
매수가
0.00
매도가
0.00
거래량
0.00
0.00 일간 변동폭 0.00
28.035 52주 범위 28.035
market_cap
5.596B
전일 종가
28.035
개장가
-
최근 거래 시간
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
27
발행 주식
199,600,000
배당수익률
-
주가수익률
2.36
주당순이익(EPS)
11.86
매출
98.29M
순이익
2.37B

Ishares Msci India Etf 정보

섹터
Mgmt Invt Offices, Open-end
산업
Mgmt Invt Offices, Open-end
웹사이트
www.ishares.com
본부
Wilmington, Delaware, USA
설립됨
-
Ishares Msci India Etf is listed in the Mgmt Invt Offices, Open-end sector of the 런던증권거래소 with ticker 0JKT. The last closing price for Ishares Msci India Etf was 28.04 €. Over the last year, Ishares Msci India Etf shares have traded in a share price range of 28.035 € to 28.035 €.

Ishares Msci India Etf currently has 199,600,000 shares in issue. The market capitalisation of Ishares Msci India Etf is 5.60 € billion. Ishares Msci India Etf has a price to earnings ratio (PE ratio) of 2.36.

0JKT 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10028.03528.03528.03500DE
40028.03528.03528.03500DE
120028.03528.03528.0352728.035DE
260028.03528.03528.0351528.035DE
520028.03528.03528.035828.035DE
1560028.03528.03528.035328.035DE
2600028.03528.03528.0357128.035DE

0JKT - Frequently Asked Questions (FAQ)

What is the current Ishares Msci India Etf share price?
The current share price of Ishares Msci India Etf is 28.035 €
How many Ishares Msci India Etf shares are in issue?
Ishares Msci India Etf has 199,600,000 shares in issue
What is the market cap of Ishares Msci India Etf?
The market capitalisation of Ishares Msci India Etf is EUR 5.6B
What is the 1 year trading range for Ishares Msci India Etf share price?
Ishares Msci India Etf has traded in the range of 28.035 € to 28.035 € during the past year
What is the PE ratio of Ishares Msci India Etf?
The price to earnings ratio of Ishares Msci India Etf is 2.36
What is the cash to sales ratio of Ishares Msci India Etf?
The cash to sales ratio of Ishares Msci India Etf is 56.93
What is the reporting currency for Ishares Msci India Etf?
Ishares Msci India Etf reports financial results in USD
What is the latest annual turnover for Ishares Msci India Etf?
The latest annual turnover of Ishares Msci India Etf is USD 98.29M
What is the latest annual profit for Ishares Msci India Etf?
The latest annual profit of Ishares Msci India Etf is USD 2.37B
What is the registered address of Ishares Msci India Etf?
The registered address for Ishares Msci India Etf is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Ishares Msci India Etf website address?
The website address for Ishares Msci India Etf is www.ishares.com
Which industry sector does Ishares Msci India Etf operate in?
Ishares Msci India Etf operates in the MGMT INVT OFFICES, OPEN-END sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

토론

전체 피드 보기
boarddork boarddork 6 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 6 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 7 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 8 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 8 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 9 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 11 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 12 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 12 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 13 분 전
Whats 305
RNVA
theorysuit theorysuit 15 분 전
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 15 분 전
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 15 분 전
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 16 분 전
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 16 분 전
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 17 분 전
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 18 분 전
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 18 분 전
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 18 분 전
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX

최근 히스토리

LSE
0JKT
Ishares Msci India Etf
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유